This is the baseline formulation, and stability data for these preparations is the most widely available
Pfizer's berobenatide is in Phase 3 with Phase 2b data showing weight loss in the high teens
Not all peptides are created equal
The safety data available derive from Phase 2 clinical trials (Jastreboff et al., NEJM, 2023), which, whilst informative, represent a relatively limited population and duration of follow-up compared to post-marketing surveillance
Some peptide stability data suggests that well-stored reconstituted peptides can maintain acceptable potency for up to 6 weeks, but this depends heavily on the specific peptide, the bacteriostatic water quality, and contamination avoidance
Step 1 Book Book online or call (480) 674-8268